Kelman-Lazarov, Inc. - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 175 filers reported holding ANTARES PHARMA INC in Q4 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Kelman-Lazarov, Inc. ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2021$62,000
+3.3%
15,0000.0%0.02%
-4.3%
Q4 2020$60,000
+46.3%
15,0000.0%0.02%
+21.1%
Q3 2020$41,0000.0%15,0000.0%0.02%0.0%
Q2 2020$41,00015,0000.02%
Other shareholders
ANTARES PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 500,000$2,180,0004.34%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,535,727$11,056,0003.87%
Sargent Investment Group, LLC 3,596,250$15,680,0003.72%
Rubric Capital Management LP 9,500,000$41,420,0002.61%
PERKINS CAPITAL MANAGEMENT INC 541,783$2,362,0001.34%
ORACLE INVESTMENT MANAGEMENT INC 1,900,000$8,284,0001.14%
Venator Capital Management Ltd. 709,700$3,094,0001.05%
LEVEL FOUR FINANCIAL, LLC 120,000$523,0000.22%
OBERWEIS ASSET MANAGEMENT INC/ 200,600$875,0000.19%
Brown Advisory Securities, LLC 275,000$1,199,0000.19%
View complete list of ANTARES PHARMA INC shareholders